Found 7 matching trials
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer
PHASE1This is an open label, multi-center, Phase 1/2 clinical trial in subjects w...
Location
St. Joseph's Hospital and Medical Center
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PHASE1The purpose of this Phase 1/2, open-label, single-arm study is to determine...
Location
University of California, San Francisco, Division of Neuro-Oncology
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PHASE2The purpose of this Phase 2, open-label, single-arm study is to determine t...
Location
Sun Yat-Sen University Cancer Center
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PHASE2Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Location
University of Alabama at Birmingham
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PHASE3This is an adaptive design, randomized controlled, Phase 3 clinical trial i...
Location
Kaiser Permanente Los Angeles Medical Center
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
PHASE2The purpose of this phase 2, two arm, biomarker-driven study is to determin...
Location
University of Texas MD Anderson Cancer Center
Expanded Access to VAL-083
N/AThis is an expanded access program (EAP) for eligible participants. This pr...
Status
No Longer Available
Location
Multiple Locations